Beneficial effect of sGC activators on survival has been observed in cardiovascular disease models such as Dahl salt‐sensitive rats (Hoffmann, Kretschmer, et al., 2015) and L‐NAME‐treated renin transgenic rats (Hahn et al., 2021). Here, REN is linked to cardiovascular disorder.